NCT06357715 Effectiveness of Neurodynamic Sliding Mobilisation in the "Slump" Position in Relation to the Perceptible Pain Threshold in Asymptomatic People
| NCT ID | NCT06357715 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Rouen |
| Condition | Voluntary |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2024-10-23 |
| Primary Completion | 2026-11-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2024-10-23 with a primary completion date of 2026-11-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
According to the French National Health Agency, the use of manual therapy techniques is "possible" \[grade B\] as part of a multimodal combination of treatments for low back pain. These include so-called "neurodynamic" neural mobilisations, which aim in particular to desensitise the pain system and activate descending inhibitory pathways, with effects on pain and function in patients with nerve-related low back pain. Most of the available evidence does not explain the mechanisms involved in neural mobilisation in the slump position. Pain reduction is observed in more areas of the body with sliding techniques than with traction techniques. In this cross-over, randomised controlled trial, we therefore hypothesise that the neurodynamic sliding technique in the slump position acts on mechanisms linked to central pain modulation processes
Eligibility Criteria
Inclusion Criteria: Subjects aged 30 years or older and less than 65 years; * Subjects considered naive to neurodynamic mobilisation techniques; * Volunteers who have read and understood the information letter and have given their written consent to participate in the study; * Fluent in spoken and read French; * Effective contraception in women of childbearing age (progestin-only or intrauterine device or tubal ligation) for at least 12 months; * For postmenopausal women, a confirmatory diagnosis must be obtained (non-drug-induced amenorrhoea for at least 12 months prior to the enrolment visit); * Subject affiliated to a social security scheme. Exclusion Criteria: * Positive slump test on the day of the selection visit (production of asymmetric lumbar symptoms or painful radiations in at least one lower limb or unilateral reduction in physiological knee extension range of motion compared with the contralateral side); * Neurological and neuropathic pain assessment score (DN4) greater than 4; * Increase or decrease in sensory function in the lower limb compared with the contralateral side, as measured by Clinical Sensory Testing (CST); * Any physical exertion of perceived intensity greater than 17 on the Borg 6-20 scale in the 72 hours prior to the trial and during the trial; * Injury, complaint or symptom affecting the spine (cervical, thoracic, lumbar) and/or lower limb(s) requiring absence from work, school or leisure activities in the 12 months prior to enrolment; * History of major surgery, injury to the trunk, spine and/or lower limb(s), or history of progressive rheumatic, neurological or oncological pathology;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06357715 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 65 Years, studying Voluntary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06357715 currently recruiting?
Yes, NCT06357715 is actively recruiting participants. Contact the research team at timothee.gillot@chu-rouen.fr for enrollment information.
Where is the NCT06357715 trial being conducted?
This trial is being conducted at Rouen, France.
Who is sponsoring the NCT06357715 clinical trial?
NCT06357715 is sponsored by University Hospital, Rouen. The trial plans to enroll 54 participants.